Home/Filings/4/0001209191-19-022630
4//SEC Filing

Unninayar Kamalam 4

Accession 0001209191-19-022630

CIK 0001123494other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:00 PM ET

Size

10.1 KB

Accession

0001209191-19-022630

Insider Transaction Report

Form 4
Period: 2019-03-07
Unninayar Kamalam
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2019-03-07+18,99773,858 total
  • Award

    Common Stock

    2019-03-07+37,99554,861 total
  • Award

    Stock option (right to buy)

    2019-03-07+91,13991,139 total
    Exercise: $3.79Exp: 2029-03-07Common Stock, par value $0.01 per share (91,139 underlying)
Footnotes (5)
  • [F1]Represents a deferred stock award of 37,995 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023.
  • [F2]Includes (a) a deferred stock award of 37,995 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023; (b) a deferred stock award of 13,852 restricted stock units which vest in equal installments on January 1, 2020, 2021 and 2022; and (c) 3,014 shares of common stock held by the Reporting Person.
  • [F3]Represents a deferred stock award of 18,997 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in equal installments on March 7, 2020, 2021 and 2022, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from March 7, 2019 to the earlier of (i) March 7, 2020 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.
  • [F4]Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above.
  • [F5]The options vest in four equal installments on January 1, 2020, 2021, 2022 and 2023.

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

Entity typeother

Related Parties

1
  • filerCIK 0001720065

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:00 PM ET
Size
10.1 KB